Equities

Balchem Corp

Balchem Corp

Actions
  • Price (USD)138.50
  • Today's Change-2.14 / -1.52%
  • Shares traded111.23k
  • 1 Year change+10.37%
  • Beta0.7186
Data delayed at least 15 minutes, as of Apr 25 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

  • Revenue in USD (TTM)922.44m
  • Net income in USD108.54m
  • Incorporated1967
  • Employees1.30k
  • Location
    Balchem Corp5 Paragon DriveMONTVALE 07645United StatesUSA
  • Phone+1 (845) 326-5600
  • Fax+1 (845) 326-5742
  • Websitehttps://balchem.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Minerals Technologies Inc2.17bn84.10m2.30bn4.03k27.571.4012.841.062.582.5866.6650.980.64314.935.40538,837.902.493.812.944.4123.3723.743.876.521.694.730.37565.752.093.72-31.18-12.574.264.56
Tronox Holdings PLC2.85bn-316.00m2.74bn6.50k--1.41--0.962-2.02-2.0218.1812.350.45821.778.55438,461.50-5.054.68-5.845.4716.2122.66-11.029.050.94821.520.587822.16-17.499.40-163.58--17.4122.67
Innospec Inc1.95bn139.10m2.99bn2.40k21.602.6016.741.535.565.5677.9246.131.184.035.61812,000.008.406.6311.008.4430.3329.897.146.251.58--0.0028.89-0.75885.704.597.4120.739.64
Quaker Chemical Corp1.95bn112.19m3.37bn4.40k29.942.4418.781.736.266.26109.0076.940.70574.814.26443,934.803.521.904.052.1936.1334.334.993.061.893.390.352549.600.500517.62808.3310.8224.663.95
Scotts Miracle-Gro Co3.44bn-395.80m3.84bn2.50k------1.12-7.03-7.0360.77-6.800.83271.9611.471,374,040.00-9.602.79-12.083.6423.0929.25-11.522.660.66980.87641.15190.70-9.505.9213.12--6.354.29
H.B. Fuller Company3.51bn154.01m4.01bn7.20k26.842.2712.731.142.752.7562.5832.470.7624.856.43487,801.503.253.343.783.9229.8727.114.274.371.232.800.508724.95-6.352.92-19.64-7.4311.785.53
Arcadium Lithium PLC882.50m330.10m4.27bn2.91k2.510.400311.864.831.581.584.229.920.33282.237.11303,368.8012.45--15.05--53.3040.0137.4122.911.6018.110.1168--8.5214.8020.6921.1134.76--
Balchem Corp922.44m108.54m4.47bn1.30k41.414.2427.344.843.343.3428.4332.680.57265.417.18708,478.506.747.377.408.1132.7531.4411.7711.821.386.730.228322.11-2.117.463.016.9413.9510.94
NewMarket Corporation-100.00bn-100.00bn5.12bn2.00k--4.44----------120.10----------12.83--15.91--26.50--11.511.60--0.526230.44-2.403.3439.0711.17-8.344.80
Cabot Corp3.92bn433.00m5.16bn4.27k12.063.888.341.317.717.7169.7623.981.094.615.21919,400.2013.145.9018.558.5322.3221.1812.105.381.3011.110.470851.63-9.033.93112.1457.561.283.61
Element Solutions Inc2.33bn116.00m5.73bn5.30k49.212.4620.272.460.48120.48999.659.640.47244.805.09440,226.402.352.542.542.7839.3740.164.986.032.436.660.451935.01-8.483.54-37.43--13.16--
Olin Corp6.62bn352.50m6.35bn7.33k19.042.907.280.95852.772.7752.7118.190.84275.897.20904,176.904.404.945.415.9014.9618.155.225.660.79653.580.556228.56-27.12-0.3278-65.327.01-9.330.00
Data as of Apr 25 2024. Currency figures normalised to Balchem Corp's reporting currency: US Dollar USD

Institutional shareholders

56.28%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20234.66m14.44%
The Vanguard Group, Inc.as of 31 Dec 20233.70m11.46%
APG Asset Management NVas of 31 Dec 20232.90m8.99%
Wasatch Advisors, Inc.as of 31 Mar 20241.88m5.83%
SSgA Funds Management, Inc.as of 31 Dec 20231.21m3.76%
Conestoga Capital Advisors LLCas of 31 Dec 20231.08m3.36%
Geneva Capital Management LLCas of 31 Dec 2023767.21k2.38%
Geode Capital Management LLCas of 31 Dec 2023748.41k2.32%
Dimensional Fund Advisors LPas of 31 Dec 2023687.49k2.13%
ClearBridge Investments LLCas of 31 Dec 2023521.59k1.62%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.